Motility disorders of the small intestine: New insights into old problems

Journal of Clinical Gastroenterology

Volumn 31, Issue 4, 2000, Pages 276-281

  Kuemmerle, John F ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Gastroenterology   (United States)

Author keywords

Dysmotility; Motility disorders; Small intestine

Indexed keywords

ALOSETRON; ERYTHROMYCIN; GASTROINTESTINAL HORMONE; OCTREOTIDE; PRUCALOPRIDE; TEGASEROD;

BARIUM ENEMA; CLINICAL FEATURE; DIGESTION; ENTEROPATHY; HUMAN; INTESTINE ABSORPTION; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE MUSCLE; INTESTINE TRANSIT TIME; MANOMETRY; NUTRIENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE;

GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL;

EID: 0033659527     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200012000-00003     Document Type: Review

References (55)

1. Studies of idiopathic intestinal pseudoobstruction. II. Hereditary hollow visceral myopathy: Family studies
2. A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission
3. A case of familial visceral myopathy with atrophy and fibrosis of the longitudinal muscle layer of the entire small bowel
4. Familial visceral neuropathy with autosomal dominant transmission
5. Congenital short bowel
6. The gastrointestinal manifestations of scleroderma
7. The roetgenological appearance of the gastrointestinal tract in scleroderma
8. Intestinal involvement in progressive systemic sclerosis
9. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma
10. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases
11. Dermatomyositis and its manifestations in the gastrointestinal tract
12. Esophageal dysfunction in collagen disease
13. The esophageal lesions in dermatomyositis
14. Gastrointestinal manifestations of systemic lupus erythematosus
15. Chronic intestinal pseudoobstruction
16. Gastrointestinal manifestations of the muscular dystrophies
17. Small intestinal motility in myotonic dystrophy patients
18. Gastrointestinal motility dysfunction in amyloidosis
19. Amyloidosis and chronic intestinal pseudoobstruction
20. Disorders of gastrointestinal motility in neurologic diseases
21. Dementia in Parkinson's disease in association with diffuse Lewy body disease
22. Drug-induced disorders of the small bowel
23. Megacolon and neurofibromatosis. A neuronal intestinal dysplasia
24. Abnormalities of interdigestive motility of the small intestine in patients with Chagas' disease
25. Gastrointestinal transit in thyroid disease
26. Hypoparathyroidism: A review of the literature and report of two cases in sisters, one with steatorrhea and intestinal pseudoobstruction
27. Disorders of gastrointestinal motility associated with diabetes mellitus
28. There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis
29. Intestinal transit in insulin-dependent diabetics
30. Gastrointestinal motility disorders in patients with diabetes mellitus
31. Treatment of diabetic diarrhea with clonidine
32. Coeliac disease presenting with intestinal pseudoobstruction
33. 4 receptor agonists initiate the peristaltic reflex in human, rat and guinea pig intestine
34. 4 receptor agonists and δ-opioid receptor antagonists act synergistically to stimulate colonic propulsion
35. 4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon
36. Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents
37. Direct and indirect actions of 5-hydroxytryptamine on the discharge of mesenteric afferent fibers innervating the rat jejunum
38. 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat
39. Towards a less costly but accurate test of gastric emptying and small bowel transit
40. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: An analysis of clinical outcome
41. Ultrasonography of the small bowel after oral administration of anechoic contrast solution
42. The patterns of small bowel motility: Physiology and implications in organic disease and functional disorders
43. Motilin and the interdigestive migrating motor complex in man
44. Somatostatin and the interdigestive migrating motor complex in man
45. Pancreatic polypeptide and interdigestive migrating motor complex in humans
46. Small bowel manometry: Short or long recording sessions?
47. Characterization of small intestinal pressure waves in ambulant subjects recorded with a novel portable manometric system
48. Effects of octreotide on manometric variables in patients with neuropathic abnormalities of the small bowel
49. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis
50. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction
51. Review article: Clinical pharmacology of alosetron
52. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomized, placebo-controlled trial
53. 4 agonist, prucalopride, in healthy humans
54. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome